October 1, 2022

It’s the climb: Ascending biotech’s career ladder without losing balance ft. Dr. Jo Viney

Dr. Jo Viney is currently the CEO of Seismic Therapeutics. Prior to this position, she was the president, chief scientific officer, and co-founder of Pandion Therapeutics, now a wholly-owned subsidiary of Merck & Co, where she developed novel therapeutics designed to address the unmet needs of patients living with autoimmune diseases. Prior to founding Pandion, Dr. Viney worked at Immunex, Amgen, and most recently Biogen where she served as a senior vice president of the drug discovery organization. Jo has also been an advocate for workplace inclusiveness. From 2015 – 2020, she served on the Board of WEST (Women in the Enterprise of Science and Technology), a non-profit organization supporting early to mid-career women, and served as the President from 2017-2018. 

BTBA had the fortune of working with Jo in March 2021 at the event of “𝘾𝙤𝙣𝙫𝙚𝙧𝙨𝙖𝙩𝙞𝙤𝙣 𝙬𝙞𝙩𝙝 𝙒𝙤𝙢𝙚𝙣 𝙇𝙚𝙖𝙙𝙚𝙧𝙨 - 𝗘𝗾𝘂𝗮𝗹𝗶𝘁𝘆 𝗮𝗻𝗱 𝗘𝗾𝘂𝗶𝘁𝘆 𝘁𝗼 𝗹𝗲𝗮𝗱𝗲𝗿𝘀𝗵𝗶𝗽,” and it is our great honor to have Jo being the Keynote Speaker of 2022 BTBA Annual Symposium. Let’s find out what she has shared with us from the special podcast episode!

Seismic Therapeutics 的創辦人暨執行長 Dr. Jo Viney 是一位優秀傑出的免疫學家,畢生致力於開發大分子藥物,並有多項其所帶領開發的藥物進入臨床試驗及上市。其所創辦的Pandio Therapeutics 更於2021年被美國默克(Merck & Co.) 18.5億美金的天價收購。除了在事業上和科學上的貢獻,她同時也是位具備領袖氣質和胸懷的前輩,為生技產業的女性後輩們樹立典範。除了願意提攜後晉、也自身經歷鼓勵並幫助後輩們規劃職涯道路、輔佐女性專業經理人創業

Time Stamps:

  • Speaker Introduction: Dr. Jo Viney (2:14)
  • Jo’s Background and Training (3:28)
  • Jo’s Management and Leadership style (12:33)
  • How do we achieve Inclusiveness and Diversity (28:39)
  • What can we all do (37:25)

More episodes

Load more

Podbean App

Play this podcast on Podbean App